These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin. Maddur MS; Kaveri SV; Bayry J Trends Immunol; 2017 Nov; 38(11):789-792. PubMed ID: 28916232 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin attenuates experimental autoimmune arthritis by inducing reciprocal regulation of Th17 and Treg cells in an interleukin-10-dependent manner. Lee SY; Jung YO; Ryu JG; Kang CM; Kim EK; Son HJ; Yang EJ; Ju JH; Kang YS; Park SH; Kim HY; Cho ML Arthritis Rheumatol; 2014 Jul; 66(7):1768-78. PubMed ID: 24644005 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. Kazatchkine MD; Kaveri SV N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745 [No Abstract] [Full Text] [Related]
6. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis. Othy S; Hegde P; Topçu S; Sharma M; Maddur MS; Lacroix-Desmazes S; Bayry J; Kaveri SV J Immunol; 2013 May; 190(9):4535-41. PubMed ID: 23526819 [TBL] [Abstract][Full Text] [Related]
7. Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin. Othy S; Topçu S; Saha C; Kothapalli P; Lacroix-Desmazes S; Käsermann F; Miescher S; Bayry J; Kaveri SV Eur J Immunol; 2014 Jul; 44(7):2059-63. PubMed ID: 24700174 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. Maddur MS; Vani J; Hegde P; Lacroix-Desmazes S; Kaveri SV; Bayry J J Allergy Clin Immunol; 2011 Mar; 127(3):823-30.e1-7. PubMed ID: 21281961 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of immune regulation by IVIG. Ballow M Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):509-15. PubMed ID: 25337683 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation. MacMillan HF; Lee T; Issekutz AC Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680 [TBL] [Abstract][Full Text] [Related]
11. Targeting T regulatory cells in autoimmune diseases. Toubi E Isr Med Assoc J; 2008 Jan; 10(1):73-6. PubMed ID: 18300580 [TBL] [Abstract][Full Text] [Related]
12. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Miyoshi H; Uchida K; Taniguchi T; Yazumi S; Matsushita M; Takaoka M; Okazaki K Pancreas; 2008 Mar; 36(2):133-40. PubMed ID: 18376303 [TBL] [Abstract][Full Text] [Related]
14. Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases. Petta F; De Luca C; Triggiani M; Casolaro V Curr Opin Pharmacol; 2014 Aug; 17():1-11. PubMed ID: 24874003 [TBL] [Abstract][Full Text] [Related]
15. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008. Shoenfeld Y; Blank M; Abu-Shakra M; Amital H; Barzilai O; Berkun Y; Bizzaro N; Gilburd B; Zandman-Goddard G; Katz U; Krause I; Langevitz P; Mackay IR; Orbach H; Ram M; Sherer Y; Toubi E; Gershwin ME Isr Med Assoc J; 2008 Jan; 10(1):13-9. PubMed ID: 18300564 [No Abstract] [Full Text] [Related]
16. Serum from patients with autoimmune diseases induces in vitro production of disease-associated antibodies by peripheral blood mononuclear cells from normal subjects. Kanazawa H; Eguchi K; Mine M; Ikari N; Kurata A; Fukuda T; Matsunaga M; Nagataki S J Clin Endocrinol Metab; 1986 Sep; 63(3):683-8. PubMed ID: 2942556 [TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin and autoimmune disease. El-Shanawany T; Jolles S Ann N Y Acad Sci; 2007 Sep; 1110():507-15. PubMed ID: 17911466 [TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease. Czernik A Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786 [No Abstract] [Full Text] [Related]
19. Increased blood plasma concentrations of TGF-beta1 and TGF-beta2 after treatment with intravenous immunoglobulins in childhood autoimmune diseases. Rissmann A; Pieper S; Adams I; Brune T; Wiemann D; Reinhold D Pediatr Allergy Immunol; 2009 May; 20(3):261-5. PubMed ID: 18761651 [TBL] [Abstract][Full Text] [Related]
20. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells. Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]